ARC Capital - CES Asia 2017 Shanghai

ARC Capital – CES Asia 2017 Shanghai

This Week, June 7th-9th 2017, ARC Capital headed to CES Asia 2017 Shanghai, to discover new opportunities involving tech products in China.

There are more than 450 exhibitors from 22 countries, regions and territories. From self-driving vehicles to augmented and virtual reality. CES 2017 will reveal the future of consumer technology in this dynamic region.

We will further enhance our network by finding great opportunities in this sector and creating new chances for companies and investors.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission